Trials / Completed
CompletedNCT05809076
Effects of Gamma-tACS on EEG Periodic Activity
Evaluation of the Effects of Gamma-tACS on the Periodic Activity of Neural Signals as a Function of State-dependency
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- IRCCS San Camillo, Venezia, Italy · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
In this study on healthy subjects, the effect of transcranial alternating current stimulation (tACS) will be investigated. In particular, the distinction between periodic and aperiodic electroencephalogram (EEG) activity will be considered, as well as the state-dependency phenomenon. Participants will take part in two experimental sessions that will include tACS stimulation (one real, one control). Before, during, and after stimulation, subjects will have their EEG recorded during rest or during tasks. The aim of this study is to investigate how the modulatory effects of gamma-tACS interact with intrinsic neural activity, measured in terms of periodic and aperiodic activity, as well as neurophysiological and behavioral modulation, taking into consideration the state-dependency phenomenon, which refers to the brain's activation state prior to stimulation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | real tACS | tACS is a non-invasive method to induce brain modulation. It will be applied at a frequency of 40 Hz (gamma-tACS) with a peak-to-peak intensity of 2 mA. During the real tACS condition, the alternating current will be administered for 20 minutes. |
| DEVICE | sham tACS | In the sham tACS condition, the current will be delivered only for the first 30 seconds and then stopped, in order to simulate the same somatosensory sensations as real tACS, but without inducing modulation. |
Timeline
- Start date
- 2021-07-20
- Primary completion
- 2023-01-18
- Completion
- 2023-01-18
- First posted
- 2023-04-12
- Last updated
- 2023-04-12
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05809076. Inclusion in this directory is not an endorsement.